Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Forums: Virtual Conferences
9th International Conference on Alzheimer's Disease and Related Disorders

Posted 14 July 2005

Return to 9th International Conference Index

Using a Genetic Approach to Understand the Vascular Basis of Alzheimer Disease

By Lindsey Farrer

Listen to Audio Presentation (Audio will take a few moments to load.) Note: Slide presentation unavailable.

Background: There is a growing body of evidence from pathological and epidemiological studies that risk factors for vascular disease also enhance risk of AD. Objectives: To evaluate the association between genes involved in vascular function and susceptibility to AD in Caucasian and African American families in the MIRAGE Study and in Wadi Ara, an inbred Israeli-Arab community with a high prevalence of AD. Methods: In the Wadi Ara sample, we profiled a subset of more than 90 AD cases and 160 elderly non-demented controls for the well-studied insertion/deletion polymorphism of the ACE gene as well as 17 ACE SNPs including 13 within the coding region, 2 within the promoter region, and two in the flanking regions whose sequence, location, and polymorphism information were obtained from the NCBI data base. Results: Significant associations were found with two intronic ACE SNPs which are less than 5 kb apart. The rs4343 G allele was present on 42% of AD subject chromosomes but on less than 18% of normal subject chromosomes (p = 0.000017). The rs4353 A allele was present on 62% of AD subject chromosomes but on 42% of normal subject chromosomes (p = 0.007). The distribution of rs4343/rs4353 haplotypes was significantly different between cases and controls (p = 0.0003). Sequencing the 10 kb region including rs4343 and rs4353 did not reveal additional polymorphic sites in this population. Analysis of these SNPs in the MIRAGE cohort is currently in progress. Conclusions: Confirmation studies in independent samples and functional data are needed to prove the contribution of ACE to AD susceptibility. These results encourage studies of other genes related to vascular function.

Citation: Lindsey Farrer, R.P. Friedland, A. Bowirrat, R.C. Green, A. Yip1, R. Inzelberg, C. Baldwin. Using a Genetic Approach to Understand the Vascular Basis of Alzheimer Disease. NeuroBiology of Aging, Volume 25, Number S2 , July 2004, Page 25

Listen to Audio Presentation (Audio will take a few moments to load.) Note: Slide presentation unavailable.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad